IL6 and major depressive disorder: So markers of platelet activation may reflect the stage of mental disease progress and are a promising biomarker to investigate the major depressive disorder and its comorbidities in the future. One study showed that depressive symptoms leading to weight gain activate two distinct inflammatory pathways: the release of IL-6 from adipose tissue and leptin-induced upregulation of IL-6 release by white blood cells.